BusinessPhoto: Business StandardZydus Lifesciences Q2 Net Profit Falls 26.6% to ₹925.5 Crore
Zydus Lifesciences reported a 26.6% decline in consolidated net profit to ₹925.5 crore for the September quarter, down from ₹1,260.9 crore in the same period last year. Revenue from operations increased to ₹7,909.6 crore, while total expenses rose sharply to ₹6,806.6 crore. The pharma business contributed 83% of sales, with India formulations revenue up 18% and North America formulations revenue up 21%.
Business Standard·




